DM - oral Flashcards

1
Q

Metformin (Biguinide) - MOA

A

inhibits glucose formation in liver, slightly reduces glucose absorption, increase glucose uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Metformin (Biguinide) - pharm

A

not metabolized, excreted by kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Metformin (Biguinide) - AE

A

decreased appetite, N, diarrhea, start low and increase gradually, does NOT cause hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Metformin (Biguinide) - contraindications

A

HF and significant renal impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Metformin (Biguinide) - caution

A

use with caution in patients with liver dz, severe infection or h/o lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sulfonylureas -names

A

glimepiride, glipizide, glyburide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sulfonylureas - MOA

A

promote insulin secretion by pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Sulfonylureas- AE

A

hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sulfonylureas - precautions

A
  • don’t give in preg or BF

- caution in patients with renal or hepatic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Meglitinides (glinides) - MOA

A

stimulate insulin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Meglitinides (glinides)- AE

A

hpoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Thiazolidinediones (TZD.Glitazone) - MOA

A

decrease insulin resistance, adjunct to metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Thiazolidinediones (TZD.Glitazone) - AE

A

URI, HA, sinusitis, myalgia, BBW - dont use in pts with HF, increase risk of bladder cancer, monitor for liver failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

alpha glucosidase Inhibitors (Acrabose) - MOA

A

delay absorption of carbs; can be used alone or adjunct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

alpha glucosidase Inhibitors (Acrabose) - AE

A

flatulence, abd distension, diarrhea, r/o liver dysfunction with long term use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dipeptidyl Peptidase - 4 Inhibitors (gliptins) - MOA

A

increase actions of incretin hormones, mono or adjunct

17
Q

Dipeptidyl Peptidase - 4 Inhibitors (gliptins) - AE

A

URI, HA, rarely pancreatitis, hypersensitivity reactions

18
Q

Sodium - Glucose Cotransporter 2 Inhibitors (SLGT2/Canagliflozin) - MOA

A

block reabsorption of filtered glucose which increases glucose in urine

19
Q

Sodium - Glucose Cotransporter 2 Inhibitors (SLGT2/Canagliflozin) - AE

A

female genital infections, UTI, increase urination

20
Q

Sodium - Glucose Cotransporter 2 Inhibitors (SLGT2/Canagliflozin) - interactions

A

rifampin, phenytoin, phenobarb (decreases levels)

r/o dehydration and hypotension with diuretics

21
Q

Glucon like peptide 1 receptor Agonists (Byetta) - MOA

A

injectable, mimics incretin hormone, adjunct only

22
Q

Glucon like peptide 1 receptor Agonists (Byetta) - AE

A

hypoglycemia, when given with sulfonyureas, N/V/D, renal impairment, hypersensitivity, weight loss, r/o developing antibodies, pancreatitis